Ashler et Manson SA (MLAEM) fair value: what the stock is really worth
As of Oct 20, 2026: fair value (intrinsic value) of Ashler et Manson SA stock €0.29, price €1.27, upside -77.2%, quality 60 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value above price?No
Good quality?Yes
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 25, 2026.
How to read this chart
60‑month range €1.26 – €4.58 · the €1.27 price screens above the €0.2900 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 25, 2026.
Follow Ashler et Manson in your weekly email
Every Wednesday you see whether Ashler et Manson is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Ashler et Manson SA, together with its subsidiaries, operates as a a mortgage and loan insurance brokerage company in France. The company offers amortizing, bullet, and bridge loans; and mortgage loan insurance products. Ashler et Manson SA was founded in 2003 and is based in Bordeaux, France.
Stock analysis
Ashler et Manson SA (MLAEM) currently trades at €1.27, while our model-based Fair Value estimate is €0.2900, 77.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of €0.2900 per share, and 0 of the 3 models we run sit above the €1.27 price.
Bear case: the Multiples group reads lowest at €0.1100, and 3 of the 3 models stay below the price. Data coverage for this calculation is low.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Financial Services sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Ashler et Manson SA reported revenue of €490K in FY2025 versus €336K in FY2021, a compound +9.9%/yr. Reported net income was €27.6K in FY2025, compounding −30.5%/yr from FY2021.
Key figures
Market cap €7.0M Micro · P/E ratio 31.8 · P/S ratio 1.79 · EPS (TTM) €0.0400 · Net margin 5.6% · Return on equity 2.0% · Return on assets (EBIT) 2.6% · Operating margin 6.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 30 out of 100 (low confidence).
What moves the price
The share trades about 61% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −59% fair-value upside, at −77%, MLAEM screens richer than that median.
Fair Value models
Bear€0.2900Fair Value €0.2900Bull€0.2900
Price €1.27 · Upside -77.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€0.0328 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.56/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−17.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−17.1%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−17.1% vs −0.1%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−26% → 6%
⚠ Revenue per share shrinking 3.4%/yr over ~8Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance Brokers · 38 stocks
Beats the industry median on 1/11 measures
Overall it trails its industry peers.
Valuation
Quality Score60 · Below median
Fair Value upside−77.2% · Bottom 25%
Profitability
Return on equity (12 months)2.0% · Bottom 25%
Return on assets1.3% · Bottom 25%
Net margin (12 months)5.6% · Below median
Operating margin (12 months)6.3% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)0.0% · Below median
Balance sheet
Debt / equity0.32× · Below median
Valuation Multiplesvs Insurance Brokers median · lower = cheaper
P/E (12 months)31.8× · Pricier than median
P/B4.99× · Pricier than median
P/S (12 months)14.26× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 39
PAST (return on equity)8· sector 52
HEALTH (low debt)84· sector 79
DIVIDEND (yield)0· sector 79
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Ashler et Manson SA Fair Value". https://www.fairvalue-calculator.com/stock/MLAEM
Frequently asked questions
Is Ashler et Manson SA (MLAEM) overvalued or undervalued?
As of Oct 25, 2026, our model estimates a fair value of €0.2900 versus a price of €1.27, about −77% upside (overvalued).
What is the fair value of MLAEM?
Our model-based fair value for Ashler et Manson SA is €0.2900 (as of Oct 25, 2026), built from audited fundamentals. The current price: €1.27.
What is the quality score of MLAEM?
Ashler et Manson SA has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Ashler et Manson SA (MLAEM)?
Our model-based price target is the fair value of €0.2900 (as of Oct 25, 2026) from 3 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Ashler et Manson SA stock forecast for 2026?
Our models put fair value at €0.2900, about −77% upside versus a price of €1.27 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Ashler et Manson SA (MLAEM)?
Ashler et Manson SA reported trailing-twelve-month revenue of about €490K (latest available figure, as of Oct 25, 2026).
What is the intrinsic value of Ashler et Manson SA (MLAEM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Ashler et Manson SA it is €0.2900 per share (as of Oct 25, 2026), against a price of €1.27. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is Ashler et Manson SA stock overvalued or undervalued in 2026?
As of Oct 25, 2026, MLAEM trades above its calculated fair value: price €1.27, fair value €0.2900, a gap of about −77% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MLAEM?
No. The price is what the market pays today (€1.27); the fair value is what the company's own numbers justify (€0.2900). For Ashler et Manson SA the two are €0.9800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Ashler et Manson SA worth?
The market values Ashler et Manson SA at about €7.0M (market capitalisation, as of Oct 25, 2026). Per share that is €1.27; our models calculate a fair value of €0.2900 per share.
What is the P/E ratio of MLAEM?
Ashler et Manson SA trades at a price-to-earnings ratio of 31.8 (as of Oct 25, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €0.2900 is built from several models across several years. Other multiples: P/B 5.0, P/S 14.3.
How solid is the balance sheet of Ashler et Manson SA (MLAEM)?
Balance-sheet figures for Ashler et Manson SA (as of Oct 25, 2026): return on equity 2.0%, debt of 0.32 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is MLAEM from its 52-week high?
Ashler et Manson SA trades at €1.27, about 61% below its 52-week high of €3.28 and 1% above the low of €1.26 (as of Oct 20, 2026). Distance from the high says nothing about value: that is what the fair value of €0.2900 is for.
Which stocks are comparable to Ashler et Manson SA?
From the same area (Financial Services) we also value Marsh & McLennan Companies, Inc, Arthur J. Gallagher & Co, Aon plc, Willis Towers Watson Public Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Ashler et Manson SA stock attractive at the current price?
The data as of Oct 25, 2026: price €1.27, calculated fair value €0.2900 (−77%), Quality Score 60/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MLAEM calculated?
We run Ashler et Manson SA through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €0.2900, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.5 % above its aggregate fair value. Ashler et Manson SA itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Ashler et Manson SA (MLAEM)?
The closing price on Oct 20, 2026 was €1.27. Our model-based fair value is €0.2900, about −77% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Ashler et Manson SA right now?
The price sits above even our optimistic bull case (€0.2900). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Ashler et Manson SA
How large is the market capitalisation of Ashler et Manson SA (MLAEM)?
The market capitalisation of Ashler et Manson SA is €7.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Ashler et Manson SA (MLAEM)?
The price-to-sales ratio of Ashler et Manson SA is 1.79 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Ashler et Manson SA (MLAEM)?
Earnings per share at Ashler et Manson SA are €0.0400 (price ÷ EPS = P/E 31.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Ashler et Manson SA (MLAEM)?
The net margin of Ashler et Manson SA is 5.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Ashler et Manson SA (MLAEM)?
The return on equity (ROE) of Ashler et Manson SA is 2.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Ashler et Manson SA (MLAEM)?
On an EBIT basis the return on assets of Ashler et Manson SA is 2.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Ashler et Manson SA (MLAEM)?
The operating margin of Ashler et Manson SA is 6.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much net debt does Ashler et Manson SA (MLAEM) carry?
The net debt of Ashler et Manson SA is €426K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Ashler et Manson SA in the live analysis
One click puts Ashler et Manson SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 25, 2026